Last reviewed · How we verify
SLS-005 Trehalose
At a glance
| Generic name | SLS-005 Trehalose |
|---|---|
| Sponsor | Merit E. Cudkowicz, MD |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- HEALEY ALS Platform Trial - Master Protocol (PHASE2, PHASE3)
- Intermediate-Sized Expanded Access Study
- HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose (PHASE2, PHASE3)
- STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia (PHASE2, PHASE3)
- SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |